Carisma Therapeutics, Inc. (CARM)
$0.00Close
SELLCRISIS · day 82
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $0
- Beta
- -9.60
- P/E (TTM)
- 0.00
- Short % float
- 0.02%
- Days to cover
- 1.3
- SI change
- +0.0%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CARM?
- LOPJLB’s latest quantitative signal on Carisma Therapeutics, Inc. (CARM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CARM in?
- Carisma Therapeutics, Inc. (CARM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Carisma Therapeutics, Inc. (CARM) do?
- Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical trial for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanc…